Clinical Trials Directory

Trials / Unknown

UnknownNCT03108430

Study of Risk Factors for Developing Inhalation Pneumonia After Inhalation

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Inhalation pneumonia (PI) is common in clinical practice but is rarely studied. For example, there are no data on the incidence of pneumonia after inhalation and risk factors or protective factors to develop one since it is known that anyone who inhaled does not necessarily develop an IP. There is no data on the benefit of treating inhalation by antibiotic therapy pre-emptively although this practice is common. In this context, this observational study wishes to take stock of the situation on the subject in order to determine what actions to implement to prevent IP.

Conditions

Interventions

TypeNameDescription
OTHERRisk factors and incidence of IP after inhalationCalculate the annual incidence of PI, the incidence of PI in inhaled patients (in each subgroup), and analyze the risk factors by logistic regression, based on the number of patients hospitalized during the study period.

Timeline

Start date
2016-08-22
Primary completion
2017-08-21
Completion
2017-08-21
First posted
2017-04-11
Last updated
2017-04-11

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03108430. Inclusion in this directory is not an endorsement.